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Introduction
Opioid use disorder has continued to rise in prevalence across the United States, with an estimated
2.5 million Americans ailing from the condition (NIDA, 2020). Medically managed detoxification
incurs substantial costs and, when used independently, may not be effective in preventing relapse
(Kosten & Baxter, 2019). While numerous studies have focused on predicting the factors of
developing opioid use disorder, few have identified predictors of readmission to medically
managed inpatient level of care. Utilizing a high-fidelity dataset from a large multi-site behavioral
health hospital, these predictors are explored.
Methods
Patients diagnosed with Opioid Use Disorder and hospitalized in the inpatient level of care were
analyzed to identify readmission predictors. Factors include patient demographics, patientreported outcome measures, and post-discharge treatment interventions. Patients re-hospitalized
to the inpatient level of care were binary labeled in the dataset, and various machine learning
algorithms were tested and evaluated for performance. Methods include random forest, gradient
boosting, and deep learning techniques. Evaluation statistics include specificity, accuracy,
precision, and Matthew's Coefficient.
Results
Overall, there was a wide variation in correctly predicting the class of patients that would readmit
to a medically managed level of inpatient detoxification. Out of the six models evaluated, three of
the six did not converge, thus not producing a viable feature ranking. However, of the other three
models that did converge, the deep learning model produced almost perfect classification,
producing an accuracy of 98%. AdaBoost and the logistic regression model produced an accuracy
of 97% and 61%, respectively. Each of these models produced a similar set of features that were
important to predicting which patient profile would readmit.
Conclusions
The results indicate that overall reduction in the Quick Inventory of Depressive Symptomology,
discharge disposition, age, length of stay, and a patient's total number of diagnoses were important
features at predicting readmission. Additionally, deep learning algorithms vastly outperformed
other machine learning algorithms and traditional statistical methods.

ii

Copyright by Brian Kay, 2021
All Rights Reserved

iii

DEDICATION

To my wife and family for endlessly supporting my endeavors to grow my knowledge.

iv

TABLE OF CONTENTS
LIST OF TABLES ............................................................................................................. viii
LIST OF ABBREVIATIONS................................................................................................ ix
LIST OF EQUATIONS ......................................................................................................... x
Introduction .......................................................................................................................... 1
Epidemiological perspective of opioid use disorder .......................................................................2
Treatment of Opioid Use Disorder ................................................................................................4
Measurement-based care in Behavioral Health.............................................................................6
Data analytics in healthcare ..........................................................................................................7
Machine learning in Behavioral Health ........................................................................................9
Ensemble-based machine learning techniques ............................................................................ 12
Random Forests .................................................................................................................................................. 12
Gradient Boosting and AdaBoost ....................................................................................................................... 12
J48 Trees ............................................................................................................................................................. 13

Further Statistical Evaluation ..................................................................................................... 14
Logistic Regression ............................................................................................................................................ 14
Deep learning...................................................................................................................................................... 14

Dataset ................................................................................................................................ 17
Methods .............................................................................................................................. 18
Results ................................................................................................................................ 23
Data statistics.............................................................................................................................. 23
Random forest ............................................................................................................................ 24
Gradient Boosting ....................................................................................................................... 25
J48 Trees .................................................................................................................................... 26
Logistic Regression ..................................................................................................................... 27
Adaboosting ................................................................................................................................ 28
Deep learning.............................................................................................................................. 29
Summary of model prediction..................................................................................................... 30

Discussion ........................................................................................................................... 32
References........................................................................................................................... 37
APPENDICES .................................................................................................................... 45
Quick Inventory of Depressive Symptomatology 16 item short form ............................................. 45
Quality of Life Enjoyment and Satisfaction Short Form (Q-LES-Q- SF) ............................................. 47
R-Statistics Code .......................................................................................................................... 48

v

CURRICULUM VITAE....................................................................................................... 59

vi

LIST OF FIGURES
Figure 1:Conceptual Diagram of a Convoluted Neuro Network .................................................. 15
Figure 2: Decision Gradient .......................................................................................................... 16
Figure 3 : Conceptual diagram for utilizing machine learning to predict outcome states ............ 23
Figure 4: Correlated variables ....................................................................................................... 24

vii

LIST OF TABLES

Table 1: Sample Demographics .................................................................................................... 19
Table 2: Confusion Matrix Example............................................................................................. 21
Table 3: Confusion Matrix: Random Forest ................................................................................. 25
Table 4: Confusion Matrix: Gradient Boosting ............................................................................ 26
Table 5: Confusion Matrix: J48 .................................................................................................... 27
Table 6: Confusion Matrix: Logistic Regression .......................................................................... 28
Table 7: Confusion Matrix: Adaboost .......................................................................................... 29
Table 8: Confusion Matrix: Deep Learning .................................................................................. 30
Table 9: Summary of evaluation statistics .................................................................................... 30
Table 10: Top five model features ................................................................................................ 31

viii

LIST OF ABBREVIATIONS
COVID-19
OUD
FDA
DSM-5
ASAM
EHR
QLESQ
QIDS
PHQ-9

Coronavirus 2019
Opioid Use Disorder
Food and Drug Association
Diagnostic and Statistical Manual of Mental Disorders, 5th
Edition
American Society of Addiction Medicine
Electronic Health Record
Quality-of-life Enjoyment and Satisfaction Scale
Quick Inventory of Depressive Symptomology
Patient Health Questionaire- 9

ICD-10
HIPAA
ROAS
TP
TN
FP
FN

International Classification of Diseases 10th edition
Health Insurance Portability and Accountability Act
Rogers Outcome Assessment System
True Positive
True Negative
False Positive
False Negative

ix

LIST OF EQUATIONS
Equation 1: Logistic Regression ................................................................................................... 14
Equation 2: Sensitivity .................................................................................................................. 21
Equation 3: Precision .................................................................................................................... 21
Equation 4: Accuracy .................................................................................................................... 22
Equation 5: Matthews Correlation Coefficient ............................................................................. 22

x

Introduction

Opioid use disorder has continued to rise in prevalence across the United States, with an
estimated 2.5 million Americans ailing from the disease in 2020 alone (NIDA, 2020). In addition
to the Coronavirus 2019 (COVID-19) pandemic proliferating across the United States, there are
indications that there will be a surge of opioid use throughout the pandemic and afterward
(Wakeman et al., 2020). With cases continuing to increase, not only may there be a lack of
treatment facilities to handle the influx of patients, but an economic burden on individuals and
healthcare payers if the cost of care is not effectively managed. With medically managed
detoxification incurring substantial costs for a single episode of care, and when used
asynchronously, it may not effectively prevent relapse (Kosten & Baxter, 2019). One strategy to
reduce these costs would be to reduce the probability that an individual readmits to the same care
post-discharge level.
Previously, insights for a whole episode of care were difficult to ascertain; however, it is now
more plausible through the increased systematic collection of healthcare data and advanced data
analytics. Using machine learning techniques, researchers can better identify factors that
precipitate health outcome states leading to better long-term health conditions. In addictions
research, a myriad studies have focused on predicting the characteristics of developing opioid use
disorder; however, few have identified predictors of readmission to medically managed
withdrawal at a medically managed inpatient level of care. The lack of information represents a
gap in the literature and valuable insights into individuals suffering from opioid use disorder while
enhancing long-term positive outcomes.
Utilizing a high-fidelity dataset from a large multi-site behavioral health hospital, these
predictors are explored. This work seeks to apply advanced data analytic techniques such as
1

supervised machine learning to effectively predict which factors may lead to more intensive levels
of care in individuals with opioid use disorder. Furthermore, these predictions can serve as
practical decision support to reduce the overall spend associated with opioid use disorder. Finally,
this work seeks to evaluate different machine learning types and advanced analytics to garner
insight into predictors of readmission. Further evaluating the use and application of machine
learning algorithms in healthcare, specifically mental and behavioral health.

Epidemiological perspective of opioid use disorder

Opioids are natural or synthetic chemicals that interact with particular parts of one's brain
chemistry. Opioids are known for reducing the feeling of pain in one's body, hence the use
traditionally as pain relievers (Rosenblum et al., 2008). Opioids, in their chemical form, have
been used extensively post-surgery, through cancer treatment, or in palliative care. While
effective for reducing pain in many individuals, opioids can produce many side effects, such as
nausea, euphoria, and drowsiness. Many times, these side effects are managed using added
prescription medications. Opioids as a drug class are extensive and varied, with many opioids
having differences in their chemical composition. The chemical composition differences can also
affect the potency of the opioid, producing a range of effects— with one of the most potent
opioids being Fentanyl. Overarchingly, opioids fall into the Schedule II drug class as
characterized by the Federal Drug Administration (FDA). Meaning they have a high potential of
abuse or physical dependence.
Even though opioids can be used therapeutically in the aforementioned cases, opioids have
highly addictive properties. Many individuals find themselves addicted to opioids after being
legally prescribed opioids for therapeutic intent. When an individual uses opioids in a
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problematic fashion, they may be diagnosed with opioid use disorder. Opioid use disorder is
typically a lifelong chronic disorder and is managed using treatment, medications, and behavioral
therapy. According to the Diagnostic and Statistical Manual of Mental Health Disorder 5th
Edition (DSM-5), the gold standard for diagnosing mental and behavioral disorders (American
Psychiatric Association, 2013). An individual need to meet two of the following criteria in order
to be diagnosed with opioid use disorder:
•

Taking larger amounts or taking drugs over a longer period than intended.

•

Persistent desire or unsuccessful efforts to cut down or control opioid use.

•

Spending a great deal of time obtaining or using the opioid or recovering from its effects.

•

Craving, or a strong desire or urge to use opioids

•

Problems fulfilling obligations at work, school, or home.

•

Continued opioid use despite having recurring social or interpersonal problems.

•

Giving up or reducing activities because of opioid use.

•

Using opioids in physically hazardous situations.

•

Continued opioid use despite ongoing physical or psychological problem likely to have
been caused or worsened by opioids.

•

Tolerance (i.e., need for increased amounts or diminished effect with continued use of the
same amount)

•

Experiencing withdrawal (opioid withdrawal syndrome) or taking opioids or a closely
related substance) to relieve or avoid withdrawal symptoms.

3

The DSM-5 allows for clear criteria of individuals who meet the criteria for opioid use
disorder. Furthermore, these diagnostic criteria are considered the gold standard, which allows a
diagnosis to be consistent between location and provider.

Treatment of Opioid Use Disorder
The treatment of opioid use disorder (OUD) differs by level of treatment intensity and
may include different levels of care. The American Society of Addiction Medicine (ASAM) has
defined criteria for which level of care an individual should be placed to manage their treatment
of opioid use disorder. This criterion is referred to ASAM criteria. ASAM criteria are multidimensional which seek to have a holistic assessment of the intensity of services required by an
individual. The ASAM criteria are composed of six distinct dimensions, which include the
following, acute intoxication and/ withdrawal potential, biomedical conditions and
complications, emotional, behavioral, or cognitive conditions, readiness to change, relapse,
continued use, or continued problem potential, and recovery living environment. The severity
and ranking of each of these levels drive treatment intensity, and individuals should be placed.
With “level 1" being outpatient services and “level 4" medically managed intensive inpatient
services (About the ASAM Criteria).
When an individual is classified at “level 4" for ASAM criteria, they need the most
intensive addiction treatment. ASAM “level 4” is a medically managed intensive inpatient
services are a 24-hour treatment that offers nursing care, a daily session with a medical provider,
and at least 16 hours of counseling. The intensity of this level of care is intended to help manage
much of the medical components associated with detoxification from opioids. The length of stay
varies due to the severity of one's symptoms but typically ranges from three days to seven days.
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Given that an individual is in a monitored facility, there is a multitude of information collected
through their treatment, including a comprehensive psychosocial assessment, a thorough nursing
assessment, and a social and familial assessment. These assessments supply a base of
information for the treatment team to properly treat all aspects of one's condition.
This includes comprehensive demographic information, diagnosis following the DSM-5,
medication history, current medications, and socioeconomic traits. Additionally, much of the
data is temporal, with values changing throughout their treatment in the intensive level of care.
The cost of medically managed detoxification may incur high costs throughout the course
of one's treatment. In an ASAM “level 4" inpatient, costs per stay are significant, with the
average stay totaling approximately $4,500 (Substance Abuse and Mental Health Services
Administration 2006). With a high rate of relapse for OUD, it is possible that over the course of
one's lifetime, they accumulate significant costs associated with readmitting to medically
managed detoxification.
The use of FDA-approved recovery medications is also a significant next step in the longterm treatment of OUD and is becoming a critical component of medically managed
detoxification. Currently, in the United States, there are three FDA approved recovery
medications, Methadone, buprenorphine, and naltrexone. All of the medications work by
targeting the μ-opioid receptor. Both Methadone and buprenorphine are considered agonists in
the treatment of OUD, which reduce cravings for use and are typically prescribed for long-term
use. Naltrexone, on the other hand, is an antagonist, extinguishing the effects of opioids rapidly.
Due to this, naltrexone is typically one of the first responses to overdose, as it is broadly used in
emergency services. With Methadone and buprenorphine increasing in utilization for long-term
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treatment of OUD, many medically managed detoxification programs are initiating these
medications during a patient's treatment (Volkow, 2018).

Measurement-based care in Behavioral Health
An essential step at improving the efficacy of behavioral health treatment and increasing
data collection in behavioral health is through the use of measurement-based care. The use of
measurement-based care in the psychiatric setting is considered a best practice but is limited in
the field due to implementation challenges and providers' willingness to incorporate
measurement-based care in their workflow. It is estimated that only 17.9% of psychiatrists and
11.1% of psychologists in the United States routinely administer symptom rating scales to their
patients (Zimmerman & McGlinchey, 2008).
Measurement-based care is the systematic administration of symptom rating scales to
drive clinical decision-making at the level of the individual patient. It is ultimately constructed to
increase efficiency, accuracy, and consistency of symptom assessment and allow the provider to
detect signals of non-response better. These clinical measures are well-validated and
psychometrically sound, allowing the identification of behavioral health conditions and tracking
treatment process over time. These measures may also be employed to assess if treatment
interventions effectively treat a patient's symptoms. Providers of behavioral health treatment
have constructed protocols to administer these measures systematically, with patients receiving a
battery of assessments at admission, at defined intervals within treatment, and discharge. This
systematic remeasurement is critical for guiding interventions, and the measures utilized have
been designed to be clinically actionable. This provides direct benefit to patients who are
completing these measures as it guides the interventions in their treatment. It also allows
clinicians to detect better if a patient is experiencing worsening symptoms; typically, mental
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health providers only detect symptom regression 21.4% in their patients without the aid of
clinical assessments (Hatfield et al., 2010). Additionally, measurement-based care sets the
foundation for robust outcome reporting, the ability to aggregate patients' treatment response not
only over a single episode of time but aggregated across a location or treatment service.
Typically, measures administered in a psychiatric population may include a quality-oflife measure and depression inventories. Given that there is a high comorbidity of depression
with opioid use disorder, many inpatient psychiatric providers choose to measure this construct
over treatment systematically. The quality-of-life enjoyment and satisfaction scale (QLESQ) is a
16-item measure that quantifies an individual's quality of life in 16 different domains. The
measure is self-report, psychometrically valid, and short of administering (Endicott et al., 1993).
The quick inventory of depressive symptomology (QIDS) is a 16-item depression inventory that
is self-reported. The inventory allows the patient to endorse symptoms of hopelessness, weight
loss, fatigue, sleep disturbance, and suicidal ideation. This assessment is psychometrically sound,
easy to administer, and as well published in the field. Additionally, the assessment allows an
individual to rate their depression symptoms over time, quantifying depression symptomology
over time (Rush et al., 2003).

Data analytics in healthcare

With the increase of data being collected through the use of EHR's and the ability for
more advanced data analysis to better predict disease, outcomes, and the optimal treatments, the
use of data analytics has proliferated in healthcare. Additionally, the amount of data within the
healthcare setting has continued to increase exponentially year over year. In 2013, it was
estimated that 153 exabytes of health care data were collected, with 2021 collecting more than
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2,314 exabytes (Banks, 2020). Furthermore, it is anticipated that in 2022, there will be a
zettabyte of healthcare data collected. One zettabyte of data is equivalent to 152 million years of
Ultra High Definition 8k video. This the sheer volume of data collected and large datasets
amassing, healthcare is primed for applying advanced analytic techniques to aid in the analysis
and uncover new insights at a rate that has not been encountered before.
The application of data analytics can be grounded in the types of analytics. There are
three major types of analytic categories: descriptive analytics, predictive analytics, and
prescriptive analytics. Where descriptive analytics is inferencing information from a sample or a
dataset, these inferences typically summarize the data through means, medians, or mode to
provide a representation of the sample or a larger population. Predictive analytics is the
extraction of information from a dataset and predicting trends and behavioral patterns. This helps
understand the historical patterns and perspectives that lie in datasets and how they can predict
future events. Predictive analytics can use various techniques from regression analysis, machine
learning, and time series forecasting. Finally, prescriptive analytics aim to predict and determine
the optimal decision based on a set of business rules. Prescriptive analytics is considered a
category of advanced analytics given the level of sophistication and application.
The aforementioned analytic categories are prevalent in healthcare, however, in different
frequencies. Where descriptive analytics is widespread, through day-to-day healthcare
operations, predictive and prescriptive analytics are seen less commonly. However, there has
been an increase in prescriptive analytics, particularly in the radiological space, in recent years to
aid in the identification of diseases (Choy et al., 2018). Despite the increase of these analytics in
medical-surgical applications in the healthcare sector, there have been limited applications in the
mental and behavioral. This may be due to less structured information, or data points with less
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fidelity, unlike lab values and biometric data. Despite these limitations, the ability for high
fidelity datasets in mental and behavioral health is becoming more of a reality due to the
treatment becoming more structured, evidence-based, and utilizing measurement-based care.

Machine learning in Behavioral Health
Despite the increase use of machine learning techniques in healthcare, there has been
minimal use of supervised machine learning techniques in the behavioral setting. With most
applications seeking to either predict outcome state or quantify the risk of a rare event in an
individual. In behavioral health, some of the applications of supervised machine learning
techniques have been applied to predict suicide risk (Roy et al., 2020) and predict the onset of
opioid use disorder (Ellis et al., 2019). Many of these applications follow the same methods of
supervised learning. The "learning" ascribed to machine learning techniques allows the computer
to take part of the dataset and learn patterns, and then the learned patterns are validated on
another part of the data to understand accuracy, sensitivity, and specificity. Typically, the
original dataset is split into a 70% and 30% ratio, where 70% of the cases are training, and 30%
of the cases are validation, where the output of the learned algorithm can be checked for validity.
To reduce potential bias in the dataset, cross-fold validation is applied. Cross-fold validation is
using the dataset and splitting it in diverse ways to find generalizable variables. Each time the
dataset is split, iteratively identifies generalizable variables, thus reducing bias incorporated into
a potential decision tree. The times that the cross-folds are performed varies from 10 times up to
24 times (Kohavi, 1995). Differences from each of the runs are then generalized to produce an
ensemble-based model. Typical outputs from machine learning models are called decision trees.
Decision trees consolidate the patterns from the multiple learning runs into a set of rules. An

9

added advantage to producing decision tree-based models is they can identify linear
relationships. In healthcare, relationships between outcome variables are often non-linear in
fashion, allowing machine learning to take advantage of these relationships. Utilizing these
advanced analytics, this study seeks to understand the predictive factors associated with
readmission to medically managed inpatient services for the treatment of opioid use disorder by
leveraging decision trees that allow an end-user to understand the associated factors with the
outcome state.
For example, Hatton et al. (2019) attempted to predict depression outcomes in a geriatric
population utilizing the Patient Health Questionnaire (PHQ-9) (Kroenke et al., 2001). Utilizing a
sample of 200 individuals who were "Older adults," the researchers utilized patient-reported
outcome measures to classify if individuals would maintain treatment gains post-discharge.
The authors' utilized machine learning techniques to predict if an individual who was part
of the clinical trial would maintain their gains 12-month post-discharge from the trial. The
researchers utilized bootstrapping to impute missing data in the dataset utilize the expectationmaximization method. The dataset was then split at 60:40, with 60% being training and 40%
being a validation of the algorithm. The primary algorithm utilized was gradient boosting, where
the outcome variable was a binary PHQ-9 score over or under 10. This indicated if the individual
was still endorsing depressive symptomology. The researchers also used logistic regression to
predict the same outcome variable and then assessed the machine learning algorithm's predictive
power.
Machine learning has also been utilized to understand and predict who is at risk for
completing suicide and what factors are associated with this risk. Current suicide risk prediction
today is extremely antiqued. Typically, an individual completes a structured interview with a
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trained clinician. These interviews are lengthy, and due to the training required to administer the
interview, not easily accessible to the public. Additionally, a 30-year meta-analysis has shown
that these aforementioned interviews have low power in predicting a suicide attempt. The field of
psychology has historically utilized less than advanced statistical techniques. As this is
essentially a classification problem, machine learning was an appropriate methodology to predict
attempts. Utilizing medical records from 5,543 adult patients at Vanderbilt University Medical
Center, the authors coded all E95x, International Classification of Diseases 10th Edition (ICD-10)
codes.
The author's utilized machine learning techniques in order to predict suicide attempts
temporally. They utilized individuals with a previous attempt and a control group of adults with
no prior documented history of suicide attempts. An ensemble-based learning method, random
forests, was utilized to predict the attempts. Decision trees are generated via recursive sampling
techniques of the predictor data. In this study, 500 trees were generated, and the risk estimated
was determined based on the proportion of trees that predicted the correct outcome. The authors
utilized standard demographic information from the medical record in their data. The authors
published 92% accuracy of the prediction, with a low discrepancy between precision and recall.
Both of these examples highlight an advanced state of affairs in the behavioral health
setting. Machine learning is beginning to be introduced into the field but shows promise in
achieving increased predictive power of current applications. Applying these techniques to
predict the readmission state in individuals with OUD is believed to be a current gap in the
literature.

11

Ensemble-based machine learning techniques
Random Forests

Random forest is an ensemble-based algorithm that generates many different decisions in each
iteration of the algorithm (Breiman, 2001). At its core, random forest models operate off of the
following principles:
"A large number of relatively uncorrelated models (trees) operating as a committee will
outperform any of the individual constituent models. "
The algorithm generates decision trees with subtleties in the parameters; then, it takes the
model's run with the most accuracy on each iteration. Each tree that is generated then produces a
prediction of the binary outcome variable. Each tree that accurately identifies the outcome
variable state gets a vote. The trees with the most votes become the class prediction. By
leveraging the low correlation between the models, the trees "protect" each from individuals
errors. Typically, producing a model with a good ability to predict the outcome variable.

Gradient Boosting and AdaBoost

Gradient boosting AdaBoosting is another type of machine learning algorithm that allows
the ability to predict an outcome variable. Gradient boosting comprises of three separate and
distinct elements, a loss function that is allowed to be optimized, a weak learner that makes
predictions, and an additive model to add to the weak learners to minimize the loss function
(Natekin & Knoll, 2013).
The loss function allows us to quickly evaluate the model while ensuring each model
does better than previous iterations of the model. In essence, a loss function quantifies error
between the actual results, the predicted results and is a distillation of many variables into a
12

specific number. This specific loss function number allows multiple iterations of the algorithm to
ooccur and the continued evaluation of which iteration "better" than the others (James, 2003).
A weak learner is something that is computationally simple and provides accuracy at
best, relatively poorly. These weak learners could be simple classifiers of predictors or a
regression analysis; however, they create a robust classifier or an ensemble-based classification
when these are pooled together in multiple iterations. Gradient boosting relies on the multiple
iterations of weak learners while minimizing the loss function to evaluate which weak learners
provide the best results. The additive model allows each weak learner's learnings to be applied to
each new iterative run, landing on the best solution(Joshi et al., 2002).
Adaboost or adaptive boosting is a variation on gradient boosting; the algorithm builds
off the weak learners optimizing the loss function. However, in adaptive boosting, the sample
distribution changes in each iteration. Changing the sample distributions, the weights on
mispredicted weak learners increase, thus allowing the weights of correctly predicted weak
learners to increase. This allows the algorithm to better focus on the more difficult iterations and,
in many instances, leads to better predictive power (Friedman, 2001).

J48 Trees
J48 trees, a classification algorithm, allows the algorithm to identify numerous factors in
a decision tree fashion to predict the outcome variable (Salzberg, 1994). The algorithm is a
modification of the C4.5 algorithm developed by Ross Quinlan and an extension of the iterative
dichtomiser 3, developed by the University of Waikato. The algorithm builds multiple decision
trees utilizing the concept of information entropy. Since this is an ensemble-based algorithm,
multiple trees are built and evaluated to take the best concepts of each tree and formulate them
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down to one final tree. J48 trees are available in multiple different code types, including Rstatistics, Python, and open-source Java.

Further Statistical Evaluation
Logistic Regression
Logistic regression is a common type of multivariate statistic which allows for the
prediction of a binary outcome variable. Logistic regressions are wildly used in the psychiatric
setting to evaluate treatment outcomes and the evaluation of psychometrics. Logistic regressions
are derived from using a logistic function where the binary outcome variable is fit to regression
and then predicted as a categorical binary variable. The general logistic regression equation can
be derived as the following, where P is the probability of the state occurring, and a + bX is the
regression equation:

Equation 1: Logistic Regression
Logistic regression
 P 
ln 
 = a + bX
 1− P 

Deep learning
Deep learning is another machine learning technique that utilizes neural networks to
predict outputs from a dataset. Deep learning mimics the thinking of an animal's brain by
simulating different layers that aid in the algorithm's decision-making process. These layers are
the input layer, the hidden layer, and the output layer. The input layer is the data fed into the
algorithm and the data that will be utilized in the mathematical computations of the hidden layer.
The hidden layer in a deep learning algorithm is where the algorithms mathematical connections
are made. There could be a vast number of hidden layers depending on the complexity of the
14

problem. The output layer is where the predicted value from the model is exposed, or the
prediction is made in the case of opioid prediction readmission; this would be the prediction if
the patient were readmitted into treatment or not readmitted into treatment (Indolia et al., 2018)

Figure 1:Conceptual Diagram of a Convoluted Neuro Network

Conceptual Diagram Convoluted Neural Network

Image Credit: Jordan (2017)

Deep learning also relies on the use of a loss function, but in deep learning algorithms, it
is called gradient descent. The gradient descent is a function where we could minimize the total
number of errors in each associated model. The reduction in the area is due to modifying the
weights in small increments on each of the input variables, which, once iterated over time, allows
the cost function to be reduced. Because these weights are iterated many times, deep learning is a
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computationally costly algorithm. Graphically depicted, J(w) is the function of error in the
model, and w being the global cost minimum. In essence, the model attempts to reduce the total
amount of error by adjusting weights to reach the Jmin(w), the lowest amount of global error in
the outputs (Ruder, 2016).

Figure 2: Decision Gradient
Decision Gradient

Image credit: Raschka (2020)

Unfortunately, this results in a "black box" where simple sets of rules are not easily
obtained from the model due to complex interactions and relationships. Deep learning, however,
has the capability of producing highly accurate models and has been utilized in pathology
applications to identify lymph node metastases more accurately than a panel of pathologists
(Ehteshami Bejnordi et al., 2017).

16

Dataset
The dataset utilized in this analysis was a de-identified dataset provided by Rogers
Behavioral Health. Permission to utilize data was obtained by Rogers Behavioral Health, and
ethical considerations were reviewed by the University of Wisconsin Milwaukee Institutional
Review Board. The dataset was transmitted for analysis utilizing secure means and was received
fully de-identified according to the Health Insurance Portability and Accountability Act
(HIPAA) safe harbor method. The data was a merged dataset containing information from the
electronic health record and Rogers Outcome Assessment System (ROAS), which supplied the
patient-reported outcome measure variables. The dataset file was provided as a comma-separated
values file and securely transferred to this author, providing encryption while in transit.
The dataset included patients from an inpatient medically managed detoxification for
opioid use disorder unit with patients discharged from 2017 through 2020, at three separate
facilities. Demographics that were analyzed included; age, discharge disposition, psychiatric
diagnosis, employment status, ethnicity, highest education, length of stay, marital status, if
commercial or Medicare or Medicaid insurance was utilized, the use of FDA approved recovery
medications, sex, and as well as the QIDS, and QLESQ. Finally, patient flow characteristics
were recorded with each encounter, including identifying if the patient stepped down to a less
intensive level of care such as partial hospitalization, residential treatment, or intensive
outpatient.
The dataset contains patient-reported outcome measures administered at admission to the
program, every four days after admission, and finally, within 24 hours of discharge.
Additionally, the dataset contains a flag for every encounter the patient was readmitted to the
inpatient level of care. This readmission flag was primarily utilized as the outcome variable in all
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subsequent analyses. Both the QIDS and QLESQ were self-reported, with the patient filling out
each measure electronically utilizing a tablet and the ROAS system.
Methods
The analysis, in general, followed a similar methodology for the evaluation of each
machine learning algorithm. All analysis and cleaning of the data were completed utilizing Rstatistics version 4.0.3 "Bunny-Wunnies Freak Out" (R Core Team, 2020), as was the integrated
development environmental R-Studio version 1.3.1093 (RStudio Team, 2021).
The dataset of information from the electronic health record in the patient-reported
outcome system was cleaned to remove outliers, inconsistencies in data formatting and
identifying and coercing the data into appropriate data classes in preparation for machine
learning and analysis. Individuals who were flagged as readmitted were then classified in a
binary variable stating if the patient was readmitted or has not readmitted. This binary class was
utilized as the target variable.
The dataset utilized consisted of 2,103 patients admitted to Rogers Behavioral health's
adult inpatient hospitalization unit in either Oconomowoc, West Allis, or Brown Deer,
Wisconsin, between March of 2017 and December of 2020. Patients were included in the dataset
if they had a primary diagnosis for OUD. In the sample, 160 patients readmitted back into one of
the inpatient units at Rogers Behavioral Health, the individuals were labeled as "Readmitted,"
and all individuals who did not readmit to an inpatient unit at Rogers Behavioral Health were
labeled as "No-Readmit." Demographic characteristics of the two groups are contained in Table
1:
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Table 1: Sample Demographics
Sample Demographics
Readmitted
(N=160)

No-Readmit
(N=1943)

33.93 (10.80)
19-69

34.57 (10.07)
18-79

Sex (%)
Female
Male

52 (32.5)
108 (67.5)

777 (40)
1166 (60)

Marital status (%)
Single
Separated
Married
Divorced
Widowed
Unknown

107 (66.9)
15 (9.4)
14 (8.8)
11 (6.9)
1 (.6)
12 (7.5)

1310 (67.4)
153 ( 7.9)
215 (11.1)
140 (7.2)
9 (.5)
116 (6.0)

Race
American Indian or Alaska Native
Asian
Black or African American
Hispanic or Latino
Native Hawaiian or Pacific Islander
White
Unknown

3 (1.9)
0 (0)
12 (7.5)
0 (0)
0 (0)
134 (83.8)
11 (6.9)

27 (1.4)
9 (.5)
151 (7.8)
0 (0)
7 (.4)
1602 (82.4)
147 (7)

Number of Diagnosis
Mean (SD)
Min-Max

3.72 (1.57)
1-8

3.49 (1.62)
1-8

120 (75)
11 (6.9)
10 (6.2)

1539 (79.2)
132 (6.8)
47 (2.5)

19 (11.8)

225 (11.5)

Variables
Age
Mean (SD)
Min-Max

Discharge Disposition
Home or Self Care
Left Against Medical Advice
Other Healthcare Facility
Lower Level of Care (Residential, Partial
Hospital, Intensive Outpatient)
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QIDS Total Score
Mean (SD)

14.70 (6.01)

14.01 (5.88)

QIDS Percent change admission to discharge
Mean (SD)

-.31 (.59)

-6.04 (6.02)

Recovery Medications (%)
Prescribed
Not Prescribed

96 (59.4)
65 (40.6)

1254 (64.5)
689 (35.5)

4.79 (2.35)
1-20

4.64(2.42)
1-47

Length of Stay Days
Mean (SD)
Min-Max

As readmission to a hospital setting can be constituted as a relatively rare event, the
dataset utilized was imbalanced in terms of individuals who readmitted versus those who did not
readmit. To increase the number of cases and balance the dataset, a combination of both
undersampling and oversampling was utilized. The dataset was oversampled with the readmitted
cases, and those who did not readmit undersampled without replacement. This created a dataset
with 1,010 individuals who did not readmit back to medically managed inpatient and 990
individuals who were readmitted back to treatment—all algorithms trained off the identical
training dataset and were validated utilizing an identical validation dataset.
For all of the algorithms that were utilized in the analysis, four evaluation statistics were
generated. These evaluation statistics include sensitivity, precision, accuracy, and the Matthews
coefficient. The evaluation statistics were derived utilizing a confusion matrix for each
algorithms output. A confusion matrix is a tool that allows for the representation of a model's
accuracy. The confusion matrix aids in the identification of the number of true positives (TP),
true negatives (TN), false positives (FP), and false negatives (FN). Table 2 depicts a typical
confusion matrix is constructed:
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Table 2: Confusion Matrix Example
Confusion Matrix Example
Predicted/ Actual
Positive
Negative

Positive
TP
FN

Negative
FP
TN

Sensitivity is the statistic that measures the number of true positives within the algorithm. The
higher the sensitivity value, the more accurately the algorithm was able to identify the number of
true positives. Sensitivity is derived below. In the following equation:

Equation 2: Sensitivity

𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =

𝑇𝑃
(𝑇𝑃 + 𝐹𝑁)

Precision is the positive predictive value or the amount of correct positive predictions that were
made. The higher the value on the positive predicted value, the more correct positive predictions
the algorithm could make. The calculation for precision is derived below:

Equation 3: Precision
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =
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𝑇𝑃
(𝑇𝑃 + 𝐹𝑃)

Accuracy is how many data points the model correctly predicted. The higher the value for
accuracy, the more correct true positives and true negatives that the algorithm was able to
identify. Accuracy is derived below in the following equation:
Equation 4: Accuracy

𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =

(𝑇𝑃 + 𝑇𝑁)
(𝑃 + 𝑁)

The Matthews Correlation Coefficient is derived the same way as Pearson's phi and is a
coefficient that takes into all aspects of the confusion matrix. Because the evaluation statistics
take into account both true and false positives and negatives, it is regarded as one of the most
balanced evaluation statistics. The higher the value of the Matthews coefficient, the better the
algorithms' ability to predict the binary classes. The Matthews coefficient is derived below:

Equation 5: Matthews Correlation Coefficient
𝑀𝑎𝑡𝑡ℎ𝑒𝑤𝑠 𝐶𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛 𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 =

𝑇𝑃 ∗ 𝑇𝑁 − 𝐹𝑃 ∗ 𝐹𝑁
√(𝑇𝑃 + 𝐹𝑃) ∗ (𝑇𝑃 + 𝐹𝑁) ∗ (𝑇𝑁 + 𝐹𝑃) ∗ (𝑇𝑁 + 𝐹𝑁)

In all the algorithms, feature importance was also obtained. Feature importance allows an
individual to understand which variables have a higher importance in making the overall
prediction. A graphical representation of the entire method is contained in Figure 3:
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Figure 3 : Conceptual diagram for utilizing machine learning to predict outcome states
Conceptual diagram for utilizing machine learning to predict outcome states
Conceptual Diagram for utilizing machine learning to predict re-hospitalization, including
potential strategies for ingestion to the Electronic medical record
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Five distinct types of algorithms were evaluated in terms of sensitivity, precision,
accuracy, and Matthew's Coefficient to evaluate each algorithm's overall accuracy. Before these
evaluation statistics were derived, the dataset was evaluated for collinear variables through the
use of correlation analysis. Individuals' diagnoses were highly correlated with the total number
of diagnoses. As a result, the individual diagnosis was removed from the dataset in favor of the
total number of diagnoses. Additionally, individual questions on the QIDS were correlated to the
total score of the QIDS; to keep the differentiation of the responses to the QIDS items, QIDS
total score was removed. Items 10 and 11, items 13 and 11, and items 13 and 14 were also
correlated. However, this is likely due to the design of the QIDS as multiple questions assess the
same symptoms. Due to this, it was determined that these questions remain within the dataset
despite their collinearity. Figure 4 summarizes the correlation between the variables:
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Figure 4: Correlated variables
Correlated variables

All algorithms trained off the same dataset and were validated against the same validation
dataset. The training dataset contained 758 patients who did not readmit and 742 patients who
were readmitted to medically managed inpatient detoxification. The validation dataset consisted
of 252 patients who did not readmit and 248 patients who were readmitted to medically managed
inpatient detoxification.
Results
Random forest
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A random forest model was produced utilizing the r package "Random forest" (Wiener,
2002). The algorithm was tuned with the following parameters, the initial set of trees to be
produced was 2,000 trees, omit any instances that did not have a classification label, and
proximity set as true. The random forest model produced a sensitivity of 0, a precision of 0,
accuracy of 88%, and a Matthews coefficient of .-.02 The confusion matrix in Table 3 illustrates
the output:

Table 3: Confusion Matrix: Random Forest
Confusion Matrix: Random Forest

No readmit
Readmit

No readmit Readmit
259
1
33
0

The model did well at predicting individuals who were likely to not readmit into treatment.
However, it did not accurately predict any individuals who were readmitted into treatment. The
top five features obtained through the decision trees to predicting readmission included age,
discharge disposition, payer type, and the total reduction of the quick inventory of depressive
symptomology.

Gradient Boosting
The gradient boosted model utilized the method xgbTree, through the r package
"XgBoost" (Tianqi Chen et al., 2020); the model parameters omitted any instances where there
was no label to predict class. In this model, cross-fold validation was employed, with ten
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crossfolds being applied. After training, tuning parameters were applied, including the number of
rounds equaling 150, the max depth 150, an eta of 3, and gamma of .4. The gradient boosted
model produced a sensitivity of 0%, a specificity of 100% , accuracy of 100%, and a Matthews
coefficient of 0. The confusion matrix in Table 4 illustrates the output:

Table 4: Confusion Matrix: Gradient Boosting
Confusion Matrix: Gradient Boosting
No readmit
No
readmit
Readmit

500
0

Readmit
0
0

The model performed poorly, predicting that all individuals were predicting not to readmit,
resulting in a Matthews coefficient of 0. Due this this, there was no stratification between the
binary classes in this model, and the usability of the model impacted, as all individuals were
labeled as not predicted to not readmit. The top features by importance that the model identified
were difference in the QIDS score from admission to discharge, age, length of stay, and the total
number of diagnoses.

J48 Trees

The J48 tree utilized the package "Rweka" for all model development and validation
(Hornik K, 2009). The model parameters omitted any instances where there was not a label to
predict class. Default settings were utilized in all other parameters. The J48 model produced a
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sensitivity of 0%, a precision of 0%, accuracy of 88%, a Matthews coefficient of 0, and an
accuracy of 91%. The confusion matrix in Table 5 illustrates the output.

Table 5: Confusion Matrix: J48
Confusion Matrix: J48
No readmit
Readmit

No readmit Readmit
1186
0
107
0

The model did well at predicting individuals who were likely to not readmit into treatment.
However, it did not accurately predict any individuals who were readmitted into treatment. This
resulted in a Mathews coefficient of 0. The models usability may be impacted given that the
majority of individuals were predicted not to readmit, and those predicted readmit were
incorrectly classified. The top features by importance that the model identified were age,
discharge disposition, the total number of diagnoses, the use of FDA-approved recovery
medication, and patient's length of stay on their original medically managed detoxification
encounter.

Logistic Regression

The logistic regression created utilized the base package of the r-statistics. The model
parameters omitted any instances where there was not a label to predict class. A train control was
created utilizing five cross-fold validation. Additionally, the method utilized was a general linear
model, with the family set as binomial. Default settings were utilized in all other parameters built
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within the model. The logistic regression model produced a sensitivity of 59%, a precision of
59%, an accuracy of 61%, and a Matthews coefficient of 23%. The confusion matrix in Table 6
illustrates the output.

Table 6: Confusion Matrix: Logistic Regression
Confusion Matrix: Logistic Regression

No readmit
Readmit

No readmit Readmit
175
100
100
147

The model did moderately well at predicting both those who did not readmit and those who did
readmit. The models identified more important features from the QIDS, compared to the other
models, with the top features being the QIDS item 5, QIDS item 15, QIDS item 11, the total
number of diagnoses, and the age of the patient.

Adaboosting

The AdaBoost algorithm utilized the r package "adabag" (Alfaro, 2003). The model parameters
omitted any instances where there was not a label to predict class, bootstrapped the training data
utilizing the weights of each observation, and produced a total number of iterations as 50.
Default settings were utilized in all other parameters. The AdaBoost model produced a
sensitivity of 100%, a precision of 94%, an accuracy of 97%, and a Matthews coefficient of .94.
The confusion matrix in Table 7 illustrates the output.
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Table 7: Confusion Matrix: Adaboost
Confusion Matrix: Adaboost

No readmit
Readmit

No readmit Readmit
238
0
14
248

The model did well at predicting individuals who were likely to not readmit into
treatment and well at predicting who would readmit back into treatment. The top features by
importance that the model identified were age, discharge disposition, the total number of
diagnoses, the use of FDA-approved recovery medication, and patient's length of stay on their
original medically managed detoxification encounter.

Deep learning
The deep learning model utilized the package H2o in order to build and tune the algorithm (Tom
Kraljevic & Malohlava, 2020). The model required a considerable number of hyperparameter
tuning in order to produce the best results. Parameters tuned included the number of hidden
layers, number of epochs, momentum, and downsampling. The final hyperparameter tuned
model included, 100000 epochs, 128 hidden layers, a momentum start of .2, with a momentum
ramp of 1e7. . As a result of the hyperparameter tuning, the model produced a sensitivity of 98%,
a precision of 100%, an accuracy of 99%, and a Matthews coefficient of .98. The confusion
matrix in Table 8 illustrates the output.
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Table 8: Confusion Matrix: Deep Learning
Confusion Matrix: Deep Learning

No readmit
Readmit

No readmit Readmit
248
4
0
252

The model performed exceptionally well at not only predicting who would readmit but who
would not readmit utilizing the validation training set. The top features by importance were
similar to the other models: QIDS item 16, the patient's age, the total number of diagnoses, the
length of stay of the patient's original encounter, and the overall reduction of QIDS score
throughout the stay.

Summary of model prediction
The models performed with a wide range of variation sensitivity, accuracy, precision, and
Matthew's coefficient. However, the model with the most optimal performance in terms of all the
evaluation statistics is the deep learning model. Table 9 summarizes the evaluation statistics
between all of the models.

Table 9: Summary of evaluation statistics
Summary of evaluation statistics

Random Forest
Gradient Boosting
J48
Logistic Regression
Adaboosting
Deep Learning

Sensitivity Precision Accuracy Matthews
0
0
88%
-0.02
0
0
100%
0
0
0
91%
0
59%
59%
61%
0.23
100%
94%
97%
.94
98%
100%
98%
.99
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The models produced similarly within the feature importance, will all the models selecting age as
an essential factor of readmission prediction. Additionally, all but one model selected the total
number of diagnoses as an important feature. The model's utilized items of the QIDS or the total
reduction of the QIDs as an important feature for prediction. The models ranked different
features as more important based on the model which was applied, with the logistic regression
weighting the items from the QIDs more than other models. This may be due to the logistic
regression model weighting all of the variables at equal importance, rather than an iterative,
ensemble-based decision. With the machine learning algorithms, the features were more evenly
spread between demographic variables and items on the QIDs; likely due to voting of features on
individual runs of the machine learning algorithms. Additionally, through hyperparameter
tuning, the deep learning model incorporated 128 hidden layers, allowing the model to identify
more complex interactions, not possible through the other algorithms evaluated. Table 10
summarizes each model's top five features and illustrates the overlap of the features between
each algorithm.

Table 10: Top five model features
Top Five Model Features

Feature
Age
Discharge
Disposition

Random
Forest

Gradient
Boosting

J48

Logistic
Regression

Adaboost

Deep
Learning

X

X

X

X

X

X

X

X
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X

Payer Type

X

Length of Stay
Total Number of
Dx
FDA Recovery
Meds

X

X

X

X

X

X

X

X

X

X

QIDS Item 5

X

QIDS Item 11

X

QIDS Item 15

X

QIDS Item 16
Reduction in
QIDS

X

X
X

X

X

Discussion
Advanced data analytics, particularly machine learning techniques, appears to help gain
new insights into sizeable behavioral health datasets, creating models with high accuracy at
identifying who will readmit and those who will not readmit. Of all of the models generated,
deep learning provided the overall best prediction as evaluated by the Matthews coefficient. The
ability to produce a model with such high accuracy is promising to implement these decisions
into behavioral healthcare. Additionally, the deep learning model had features consistent with the
other models evaluated, lending credence that the factors displayed in Table 3 are at the very
least correlated with identifying who is likely to readmit to an inpatient level of care.
A large amount of the models identified age, length of stay, and the total number of
diagnosis as essential features to predicting outcome class and is consistent with the current state
of the literature. The lower the age and length of stay was associated with a higher risk of
readmission.Furthmore, the higher number of total diagnosis were associated with an increased
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risk of readmission. The presence of multiple comorbidities is also congruent with the literature.
Typical comorbidities including, depression, sleep disorders, personality disorders, and anxiety
disorders (Grella et al., 2009), are all associated with OUD and all identified in the dataset. In
medically managed detoxification, the primary goal of treatment is withdrawal management,
ensuring medical stability, and discharge preparation. The ability to introduce standard
behavioral health management techniques such as cognitive-behavioral therapy (CBT) and
behavioral activation (BA) may be advantageous to reducing symptoms associated with common
comorbid disorders.
Furthermore, the relationship between the length of stay and improved outcomes is also
documented by (Oh et al., 2020), illustrating different treatment trajectories based on diagnosis
on inpatient psychiatric treatment. Identifying a longer length of stay was consistently identified
between all of the machine learning models evaluated. Length of stay in a psychiatric setting has
varied across the years and within a geographic region, with the average length of stay declining
close to the three days from the 1990s to the 2010s (Lee et al., 2012). This variation of length of
stay may likely be due to a lack of robust outcome information, where the criteria to discharge
are guided primarily through clinical judgment rather than care guidelines typical in the medicalsurgical sector. This lack of length of stay optimization may be a critical factor in the
readmission of opioid use disorder patients and psychiatric inpatients in general. The utilization
of deep learning techniques may be a critical method to establishing the optimal length of stay.
Encouragingly, many of the aforementioned features are modifiable through treatment and
giving clinicians the ability to actively reduce the probability that a patient would readmit to an
intensive level of care. Since many of these factors are collected through the standard treatment
documentation of opioid use disorder, it would be practical to implement these as a set of rules
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within the EHR. The rules can either be quantified and weighted as an overall score, illustrating
the probability of readmission, or utilized as flags for treatment interventions. By flagging which
conditions a patient met, a clinician would optimize one's length of stay, treating comorbidities
through targeted treatment interventions and proper discharge planning.
Additionally, this can create an even more robust treatment plan, individualized to not
only the individual but to long-term outcomes. Treatment designed like this introduces
personalized medicine into behavioral health in a way that is not prevalent in the space today and
may help counter some of the ethical challenges of personalized medicine in psychiatry (Evers,
2009). It can also produce a framework for treatment that would be generalizable to other
behavioral health disorders, identifying individuals’ characteristics that place the patient at a
higher risk of an adverse outcome.
However, there is a trade-off between algorithms that produce defined decision trees with
less accuracy and deep learning algorithms with increasing accuracy and more obfuscated
decision pathways. These factors may lead to less utilization of the features outputted by the
algorithm due to clinicians having hesitancy to use when the algorithm is primarily a "black box"
(Stead, 2018). With the potential lack of buy-in to utilize the information gained by the deep
learning model, the work becomes more theoretical, rather than implementing functional changes
to reduce readmission. The mistrust of deep learning techniques may prove to be a long term
barrier to adopting many insights gained by applying these techniques. Further education to
clinicians regarding machine learning techniques and the strategies on how to evaluate if an
algorithm produces a reliable and robust model may increase adoption.
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In addition to the "black box" produced by the deep learning algorithm, the other
algorithms produced very robust decision trees. For example, the AdaBoost algorithm produced
a decision tree with over 400 different decision points. Due to the sheer amount of decision
points contained in the model, there may be barriers to implementing the findings at an
individual patient level. Implementing this processing to the EHR may not only be difficult but
not feasible given the current architecture of EHR's today. Additionally, data processing modules
may need to be added to the EHR in order to achieve this level of processing.
There were also some underlying limitations within the dataset itself. All of the
readmissions analyzed were patients who were admitted and readmitted to a single behavioral
health system. This does not provide insight into the individuals who may have sought treatment
at a different health system, or a different level of care, potentially missing important features
when looking at readmissions from a more global perspective. This may bias the algorithm due
to factors such as overall satisfaction with the treatment experience and satisfaction with
providers not accounted for in the data. In essence, the data does not provide the opportunity to
parse if a patient did not readmit due to being successful in maintaining sobriety or simply if they
were unhappy with their treatment experience and sough another provider.
One way to potentially counter this limitation is data sharing with entities such as payers,
the fidelity of the outcome variable can be increased due to the payor collecting claims data not
specific to one entity. The ability to use claims data as the outcome variable could further
strengthen the predictive factors and potentially lead to other features essential to predicting
readmission, such as emergency room utilization.
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From a data analysis perspective, the dataset was unbalanced, and the use of over and
under sampling was applied, which results in duplication of readmission cases. The algorithms
learned features over duplicated cases; this may have biased the algorithm to features that were
apparent only in the duplicated cases. However, the use of undersampling and oversampling was
necessary to produce a viable model throughout the analysis. As the dataset accumulates new
patients over time, these issues may no longer be relevant; they may also be mitigated through
further collaborations with payers.
Regardless of these limitations, the use of machine learning techniques in behavioral
health appears to be a valuable next step in reducing the total number of readmissions and
potentially the costs associated with subsequent readmissions. Additionally, identifying
modifiable features may be one of the first steps to personalized medicine in behavioral health
treatment and allows for optimized treatment outcomes. As datasets in behavioral healthcare
continue to grow with high-fidelity structured data, more insights may be possible to predict
outcome states. Furthermore, with more precise education to clinical providers, the adoption of
machine learning algorithms will further increase, providing more robust and patient-driven
outcomes.
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APPENDICES

Quick Inventory of Depressive Symptomatology 16 item short form

The Quick Inventory of Depressive Symptomatology (16-Item) (Self-Report) (QIDS-SR
Name or ID: _____________________________

16)

Date: _____________________________

CHECK THE ONE RESPONSE TO EACH ITEM THAT BEST DESCRIBES YOU FOR THE PAST SEVEN DAYS.

During the past seven days...

During the past seven days...

1. Falling Asleep:

5. Feeling Sad:

0

I never take longer than 30 minutes to fall asleep.

0

I do not feel sad.

1

I take at least 30 minutes to fall asleep, less than
half the time.

1

I feel sad less than half the time.

2

I feel sad more than half the time.

2

I take at least 30 minutes to fall asleep, more than
half the time.

3

I feel sad nearly all of the time.

3

I take more than 60 minutes to fall asleep, more than
half the time.

Please complete either 6 or 7 (not both)
6. Decreased Appetite:

2. Sleep During the Night

0

There is no change in my usual appetite.

0

I do not wake up at night.

1

1

I have a restless, light sleep with a few brief
awakenings each night.

I eat somewhat less often or lesser amounts of food than
usual.

2

I eat much less than usual and only with personal effort.

2

I wake up at least once a night, but I go back to
sleep easily.

3

3

I awaken more than once a night and stay awake
for 20 minutes or more, more than half the time.

I rarely eat within a 24-hour period, and only with
extreme personal effort or when others persuade me to
eat.

3. Waking Up Too Early:
0

Most of the time, I awaken no more than 30 minutes
before I need to get up.

1

More than half the time, I awaken more than 30
minutes before I need to get up.

2

I almost always awaken at least one hour or so
before I need to, but I go back to sleep eventually.

3

I awaken at least one hour before I need to, and
can't go back to sleep.

4. Sleeping Too Much:
0

- OR 7. Increased Appetite:

I sleep no longer than 10 hours in a 24-hour period
including naps.

2

I sleep no longer than 12 hours in a 24-hour period
including naps.

3

I sleep longer than 12 hours in a 24-hour period
including naps.

There is no change from my usual
appetite.

1

I feel a need to eat more frequently than usual.

2

I regularly eat more often and/or greater amounts of
food than usual.

3

I feel driven to overeat both at mealtime and between
meals.

Please complete either 8 or 9 (not both)
8. Decreased Weight (Within the Last Two Weeks):

I sleep no longer than 7-8 hours/night, without
napping during the day.

1

0

0

I have not had a change in my weight.

1

I feel as if I have had a slight weight loss.

2

I have lost 2 pounds or more.

3

I have lost 5 pounds or more.

- OR 9. Increased Weight (Within the Last Two Weeks):
0

I have not had a change in my weight.

1

I feel as if I have had a slight weight gain.

2

I have gained 2 pounds or more.

3

I have gained 5 pounds or more.

Pg. 1 of 2

45

46

Quality of Life Enjoyment and Satisfaction Short Form (Q-LES-Q- SF)
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R-Statistics Code
### Author: Brian Kay
### Predicting readmission in OUD- Exploratory Data Analysis, and predictive models
### Updated: 12/31/2020
### PACKAGE LOAD
library(openxlsx)
library(Boruta)
library(car)
library(corrplot)
library(data.table)
library(plyr) ## Load this before dplyr
library(dplyr)
library(olsrr)
library(psych)
library(questionr)
library(randomForest)
require(caTools)
library(tidyverse)
library(caret)
library(xgboost)
library(imputeTS)
library(stringr)
library(tree)
library(FFTrees)
library(RWeka)
library(party)
library(FSelector)
library(caret)
library(pROC)
library(adabag)
library(mlbench)
library(forcats)
library(Amelia)
library(tidyr)
library(h2o)
# Run Descriptive Statistics:
# Subset to only baseline & by readmit vs non readmit
OUD_Baseline<-subset(OUD_data, phase=="Baseline")
OUD_Baseline$phase<-NULL
OUD_Baseline_ML<-OUD_Baseline[!is.na(OUD_Baseline$Readmit_Orig),]
descriptivestatsreadmit<-subset(OUD_Baseline_ML, Readmit_Orig=="Readmit")
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descriptivestatsnoreadmit<-subset(OUD_Baseline_ML, Readmit_Orig=="No Readmit")
# Summary of demographic information in each group
describeBy(OUD_Baseline_ML,OUD_Baseline_ML$Readmit_Orig=="Readmit")
describeBy(OUD_Baseline_ML,OUD_Baseline_ML$Readmit_Orig=="No Readmit")
#Frequencies for readmit
questionr::freq(descriptivestatsreadmit$sex, cum = TRUE, sort = "dec", total = TRUE) #
Discharge sex
questionr::freq(descriptivestatsreadmit$dcdisposition, cum = TRUE, sort = "dec", total = TRUE)
# Discharge disposition
questionr::freq(descriptivestatsreadmit$FDA_Recovery_Med, cum = TRUE, sort = "dec", total =
TRUE) # Recovery Medications
questionr::freq(descriptivestatsreadmit$race, cum = TRUE, sort = "dec", total = TRUE) # Race
questionr::freq(descriptivestatsreadmit$marital, cum = TRUE, sort = "dec", total = TRUE) #
Marital

# Frequencies for no readmit
questionr::freq(descriptivestatsnoreadmit$dcdisposition, cum = TRUE, sort = "dec", total =
TRUE) # Discharge disposition
questionr::freq(descriptivestatsnoreadmit$FDA_Recovery_Med, cum = TRUE, sort = "dec",
total = TRUE) # Recovery Medications
questionr::freq(descriptivestatsnoreadmit$marital, cum = TRUE, sort = "dec", total = TRUE)
#Marital
questionr::freq(descriptivestatsnoreadmit$sex, cum = TRUE, sort = "dec", total = TRUE) #Sex

questionr::freq(descriptivestatsnoreadmit$race, cum = TRUE, sort = "dec", total = TRUE) #
Race

# Understand which variables are highly correlated
corr_simple <- function(data=df,sig=0.5){
#convert data to numeric in order to run correlations
#convert to factor first to keep the integrity of the data - each value will become a number
rather than turn into NA
df_cor <- data %>% mutate_if(is.character, as.factor)
df_cor <- df_cor %>% mutate_if(is.factor, as.numeric)
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#run a correlation and drop the insignificant ones
corr <- cor(df_cor)
#prepare to drop duplicates and correlations of 1
corr[lower.tri(corr,diag=TRUE)] <- NA
#drop perfect correlations
corr[corr == 1] <- NA
#turn into a 3-column table
corr <- as.data.frame(as.table(corr))
#remove the NA values from above
corr <- na.omit(corr)
#select significant values
corr <- subset(corr, abs(Freq) > sig)
#sort by highest correlation
corr <- corr[order(-abs(corr$Freq)),]
#print table
print(corr)
#turn corr back into matrix in order to plot with corrplot
mtx_corr <- reshape2::acast(corr, Var1~Var2, value.var="Freq")
#plot correlations visually
corrplot(mtx_corr, is.corr=FALSE, tl.col="black", na.label=" ")
}
corr_simple(OUD_Impute)

#Duplicative Variables and Colinear Variables
OUD_Impute$los<-NULL
OUD_Impute$ethnic<-NULL
OUD_Impute$employment<-NULL
OUD_Impute$highest_education<-NULL
OUD_Impute$dxquatinary<-NULL
OUD_Impute$dxquinary<-NULL
OUD_Impute$dxtertiary<-NULL
OUD_Impute$Continuation<-NULL
OUD_Impute$dxprimary<-NULL
OUD_Impute$dxsecondary<-NULL
OUD_Impute$qids_percent_change<-NULL
OUD_Impute$qids_total<-NULL
missmap(OUD_Impute)
#Oversample and undersample the Dataset to balance
library(ROSE)
data_balanced_both<- ovun.sample(Readmit_Orig ~., data=OUD_Impute ,method= "both",
N=2000, seed = 123)$data
table(data_balanced_both$Readmit_Orig)
OUD_Baseline_ML<-data_balanced_both
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#Reduce dataset to feature selected variables
# Apply Random forest model
set.seed(101)
sample = sample.split(OUD_Baseline_ML$Readmit_Orig,SplitRatio=.75)
train= subset(OUD_Baseline_ML,sample ==TRUE)
test= subset(OUD_Baseline_ML,sample ==FALSE)
train<-train %>% mutate_if(is.character, as.factor)
rf<-randomForest(
Readmit_Orig ~.,
data=train,
ntree= 2000,
importance=TRUE,
proximity=TRUE,
na.action = na.omit
)
getTree(rf,1,labelVar = TRUE)
pred= predict(rf, newdata=test[-36])
cm= table(test[,36],pred)
cm

#Apply gradient boosting model
set.seed(123)
OUD_gradient <- train(
Readmit_Orig ~., data=train, method= "xgbTree",
trControl=trainControl("cv",number=10),
na.action= na.omit
)
#Best tuning parameter
OUD_gradient$bestTune
#Make predictions on the test data
pred<-predict(OUD_gradient,test)
pred.resp <- ifelse(pred >0.86, 1, 0)
predicted.classes<-OUD_gradient %>% predict(test)
head(predicted.classes)
confusionMatrix(pred.resp, Readmit_Orig, positive="Readmit")
#Compute model prediction accuracy rate
mean(predicted.classes == test$Readmit_Orig)
varImp(OUD_gradient)
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plot(varImp(OUD_gradient), top=10)
y_pred=predict(OUD_gradient,test)
err <- mean(as.numeric(pred > 0.5))
print(paste("test-error=", err))

#Apply J48
j48 <- J48(Readmit_Orig~., data = train)
summary(j48)
plot(information.gain(Readmit_Orig~., data = OUD_Baseline_ML), top=10)
y_pred=predict(j48,test)
err <- mean(as.numeric(pred > 0.5))
print(paste("test-error=", err))
#Information gain of J48
information.gain(Readmit_Orig~., data = OUD_Baseline_ML)
if(require("party", quietly = TRUE)) plot(j48)
#Apply Logistic Regression
trCntl <- trainControl(method = "CV",number = 5)
glmModel <- train(Readmit_Orig ~ .,data = train,trControl = trCntl,method="glm",family =
"binomial")
# print the model info
summary(glmModel)
glmModel
confusionMatrix(glmModel)
# generate predictions on hold back data
trainPredicted <- predict(glmModel,test)
# generate confusion matrix for hold back data
confusionMatrix(trainPredicted,reference=test$Readmit_Orig)

##adaboost
adaboost<-boosting(Readmit_Orig~ ., data=train ,boos=TRUE, mfinal=50)
predadaboost<-predict(adaboost,newdata=test)
print(predadaboost$error)
get_tree(adaboost,1)
print(predadaboost$confusion)
print(predadaboost$trees)
#Boosted model with Crossfold validation
adaboostcv<-boosting.cv(Readmit_Orig~ ., data=train ,boos=TRUE, mfinal=50, v=10)
print(adaboostcv[-1])
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## Deep Learning Model,derived from h2o tutorial
library(h2o)
h2o.init(nthreads = -1)
#Convert To H2o dataframe
train<-as.h2o(train)
test<-as.h2o(test)
#Set target variable and predictors
response<-"Readmit_Orig"
predictors <- setdiff(names(train), response)
predictors
#Model 1
m1 <- h2o.deeplearning(
model_id="dl_model_first",
training_frame=train,
validation_frame=test, ## validation dataset: used for scoring and early stopping
x=predictors,
y=response,
activation="Rectifier",
hidden=c(200,200),
epochs=1,
variable_importances=T
)
summary(m1)
head(as.data.frame(h2o.varimp(m1)))
#Model 2
m2 <- h2o.deeplearning(
model_id="dl_model_faster",
training_frame=train,
validation_frame=test,
x=predictors,
y=response,
hidden=c(256,256,256),
epochs=1000000,
score_validation_samples=10000,
stopping_rounds=2,
stopping_metric="misclassification",
stopping_tolerance=0.01
)
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summary(m2)
plot(m2)
#final Model Tuned
m3 <- h2o.deeplearning(
model_id="dl_model_tuned",
training_frame=train,
validation_frame=test,
x=predictors,
y=response,
overwrite_with_best_model=F,
hidden=c(128,128,128,128),
epochs=1000000,
score_validation_samples=10000,
score_duty_cycle=0.025,
adaptive_rate=F,
rate=0.01,
rate_annealing=2e-6,
momentum_start=0.2,
momentum_stable=0.4,
momentum_ramp=1e7,
l1=1e-5,
l2=1e-5,
max_w2=10
)
summary(m3)
h2o.performance(m3, train=T)
h2o.performance(m3, test=T)
h2o.performance(m3, newdata=train)
h2o.performance(m3, newdata=test)
#Tuning Hyperparameters
hyper_params <- list(
hidden=list(c(256,256,256),c(64,64)),
input_dropout_ratio=c(0,0.05),
rate=c(0.01,0.02),
rate_annealing=c(1e-8,1e-7,1e-6)
)
hyper_params
grid <- h2o.grid(
algorithm="deeplearning",
grid_id="dl_grid",
training_frame=train,
validation_frame=test,
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x=predictors,
y=response,
epochs=10,
stopping_metric="misclassification",
stopping_tolerance=1e-2,
## stop when misclassification does not improve by >=1% for 2
scoring events
stopping_rounds=2,
score_validation_samples=10000,
score_duty_cycle=0.025
adaptive_rate=F,
momentum_start=0.5,
momentum_stable=0.9,
momentum_ramp=1e7,
l1=1e-5,
l2=1e-5,
activation=c("Rectifier"),
max_w2=10,
hyper_params=hyper_params
)
grid
dlmodel <- h2o.deeplearning(
x=predictors,
y="bin_response",
training_frame=train,
hidden=c(10,10),
epochs=0.1
)
summary(dlmodel)
grid <- h2o.getGrid("dl_grid",sort_by="err",decreasing=FALSE)
grid
## To see what other "sort_by" criteria are allowed
#grid <- h2o.getGrid("dl_grid",sort_by="wrong_thing",decreasing=FALSE)
## Sort by logloss
h2o.getGrid("dl_grid",sort_by="logloss",decreasing=FALSE)
## Find the best model and its full set of parameters
grid@summary_table[1,]
best_model <- h2o.getModel(grid@model_ids[[1]])
best_model
print(best_model@allparameters)
print(h2o.performance(best_model, valid=T))
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print(h2o.logloss(best_model, valid=T))

hyper_params <- list(
activation=c("Rectifier","Tanh","Maxout","RectifierWithDropout","TanhWithDropout","Maxou
tWithDropout"),
hidden=list(c(20,20),c(50,50),c(30,30,30),c(25,25,25,25)),
input_dropout_ratio=c(0,0.05),
l1=seq(0,1e-4,1e-6),
l2=seq(0,1e-4,1e-6)
)
hyper_params
## Stop once the top 5 models are within 1% of each other (i.e., the windowed average varies
less than 1%)
search_criteria = list(strategy = "RandomDiscrete", max_runtime_secs = 360, max_models =
100, seed=1234567, stopping_rounds=5, stopping_tolerance=1e-2)
dl_random_grid <- h2o.grid(
algorithm="deeplearning",
grid_id = "dl_grid_random",
training_frame=train,
validation_frame=test,
x=predictors,
y=response,
epochs=1,
stopping_metric="logloss",
stopping_tolerance=1e-2
stopping_rounds=2,
score_validation_samples=10000,
score_duty_cycle=0.025,
max_w2=10,
hyper_params = hyper_params,
search_criteria = search_criteria
)
grid <- h2o.getGrid("dl_grid_random",sort_by="logloss",decreasing=FALSE)
grid
grid@summary_table[1,]
best_model <- h2o.getModel(grid@model_ids[[1]])
best_model
grid <- h2o.getGrid("dl_grid",sort_by="err",decreasing=FALSE)
best_model <- h2o.getModel(grid@model_ids[[1]])
h2o.confusionMatrix(best_model,valid=T)
best_params <- best_model@allparameters
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best_params$activation
best_params$hidden
best_params$input_dropout_ratio
best_params$l1
best_params$l2

max_epochs <- 10000 ## Add two more epochs
m_cont <- h2o.deeplearning(
model_id="dl_model_tuned_continued",
checkpoint="dl_model_tuned",
training_frame=train,
validation_frame=test,
x=predictors,
y=response,
hidden=c(128,128),
epochs=max_epochs,
stopping_metric="logloss",
stopping_tolerance=1e-2,
scoring events
stopping_rounds=2,
score_validation_samples=10000,
score_duty_cycle=0.025,
adaptive_rate=F,
rate=0.01,
rate_annealing=2e-6,
momentum_start=0.2,
momentum_stable=0.4,
momentum_ramp=1e7,
l1=1e-5,
l2=1e-5,
max_w2=10
)
summary(m_cont)
plot(m_cont)
dlmodel <- h2o.deeplearning(
x=predictors,
y=response,
training_frame=train,
hidden=c(10,10),
epochs=1,
nfolds=5,
fold_assignment="Modulo" # can be "AUTO", "Modulo", "Random" or "Stratified"
)
dlmodel
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#Binomial Model
dlmodel <- h2o.deeplearning(
x=predictors,
y="Readmit_Orig",
training_frame=train,
validation_frame = test,
hidden=c(128,128,128,128),
epochs=1000,
reproducible = T
)
summary(dlmodel)
h2o.varimp(dlmodel)
h2o.varimp_plot(dlmodel,num_of_features = 5)
plot(h2o.performance(dlmodel))
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Invited Presentations
Metric Driven Strategy for EHR Continuous Improvement , speaker at Healthcare Information
Management System Society, Orlando, FL February 12th, 2019.
Behavioral Health and Cerner: Improved Revenue and Clinical Outcomes, speaker at Cerner Health
Conference, Kansas City, MS, October 10th, 2017.
Leveraging Data Analytics to Improve Quality and Outcomes, speaker at Cerner Health Conference,
Kansas City, MS, November 16th, 2016.

Patents
Kay, B., Rousey, J., Sagrillo, K., Graphical User interface for the display of census
information— Patent in Review US, EU Design Number:002740035-0001, Granted; July 2015
Kay, B., Rousey, J., Sagrillo, K., Graphical User interface for the display of hours worked—
Patent in Review US, EU Design Number: 002725184-0001, Granted; July 2015
Kay, B., Rousey, J., Badillo, J., Jens, K., Sagrillo, K., Graphical User interface for the display of
date last worked— Patent in Review US, EU Design Number:002740373-0001, Granted; July
2015
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